Peter Greenleaf, chair of the board overseeing the $84 million InvestMaryland venture fund, is taking a CEO job with Massachusetts-based biotech company Histogenics.
Greenleaf, former president of MedImmune in Gaithersburg, will remain chairman of the InvestMaryland board, a four-year position, at the request of Governor Martin O’Malley.
Read more here.
Join the conversation!
Find news, events, jobs and people who share your interests on Technical.ly's open community Slack
Baltimore daily roundup: Mayoral candidates talk tech and biz; a guide to greentech vocabulary; a Dutch delegation's visit
Baltimore daily roundup: Medtech made in Baltimore; Sen. Sanders visits Morgan State; Humane Ai review debate
Baltimore daily roundup: An HBCU innovation champion's journey; Sen. Sanders visits Morgan State; Humane Ai review debate
